Australia markets closed

NeuBase Therapeutics, Inc. (NBSE)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.4420+0.0210 (+4.99%)
At close: 04:00PM EDT
0.4420 +0.01 (+1.84%)
After hours: 04:10PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Dec 2023)Next qtr. (Mar 2024)Current year (2024)Next year (2025)
No. of analysts0000
Avg. Estimate0000
Low estimate0000
High estimate0000
Year ago EPS-2.2-2.4N/AN/A
Revenue estimateCurrent qtr. (Dec 2023)Next qtr. (Mar 2024)Current year (2024)Next year (2025)
No. of analysts0011
Avg. EstimateN/AN/AN/AN/A
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/AN/A
Year ago salesN/AN/AN/AN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings history30/12/202230/03/202329/06/202329/09/2023
Est. EPS-3.1-2.3-2-1.82
Actual EPS-2.2-2.4-2.04-0.66
Difference0.9-0.1-0.041.16
Surprise %29.00%-4.30%-2.00%63.70%
EPS trendCurrent qtr. (Dec 2023)Next qtr. (Mar 2024)Current year (2024)Next year (2025)
Current estimate0000
7 days ago00-9-11.4
30 days ago00-9-11.4
60 days ago00-9-11.4
90 days ago00-9-11.4
EPS revisionsCurrent qtr. (Dec 2023)Next qtr. (Mar 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesNBSEIndustrySector(s)S&P 500
Current qtr.N/AN/AN/AN/A
Next qtr.N/AN/AN/AN/A
Current yearN/AN/AN/AN/A
Next yearN/AN/AN/AN/A
Next 5 years (per annum)4.00%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A